×

Growth Reports

Growth Reports
Report Name

Rapid Influenza Diagnostic Tests Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (RIDTs for Influenza A, RIDTs for Influenza B), By End-User (Hospitals & Clinics, Laboratories, Others), Countries and Companies Report

Rapid Influenza Diagnostic Tests Market is projected to register a 7.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022798  |   No. of Pages: 199

Rapid Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Over The Counter Rapid Diagnostics Test, Professional Rapid Diagnostics Test), By Application (Blood Glucose, Infectious Diseases, Cardiometabolic, Coagulation, Pregnancy & Fertility, Fecal Occult Blood, Toxicology), Countries and Companies Report

Rapid Diagnostics Market is projected to register a 8.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022797  |   No. of Pages: 199

QPCR and dPCR Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Technology (Quantitative PCR, Digital PCR), By Product (Reagents and Consumables, Instruments, Software), By Application (Clinical Application, Pathogen Testing, Oncology Testing, Blood Screening, Others), By End-User (Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories), Countries and Companies Report

qPCR and dPCR Market is projected to register a 7.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022786  |   No. of Pages: 194

QPCR Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical, Research, Forensics), By End-User (Hospitals &Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories), Countries and Companies Report

qPCR Market is projected to register a 6.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022785  |   No. of Pages: 198

Pulmonary Hypertension Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Mechanism of Action (Endothelin receptor antagonists (ERAs), Prostacyclin Analogs, Phosphodiesterase inhibitors (PDE), Soluble guanylate cyclase stimulators (sGC)), By Dosage Form (Oral, Injection, Inhalation), Countries and Companies Report

Pulmonary Hypertension Market is projected to register a 5.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022783  |   No. of Pages: 204

Pulmonary Endoscopy Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Rigid Endoscopy Devices, Flexible Endoscopy Devices, Other), By Application (Hospitals, Clinics, Others), Countries and Companies Report

Pulmonary Endoscopy Devices Market is projected to register a 7.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022782  |   No. of Pages: 200

Pulmonary Embolism Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Hospitals, Ambulatory surgical centers, Research institutes), By Route of Administration (Oral, Parenteral), Countries and Companies Report

Pulmonary Embolism Therapeutics Market is projected to register a 8.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022781  |   No. of Pages: 196

Pulmonary Arterial Hypertension (PAH) Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Mechanism of Action (Prostacyclin Analogs, Endothelin Receptor Antagonists (ERAs), Phosphodiesterase (PDE) Inhibitors, Soluble Guanylate Cyclase Stimulators (SGCSs)), By Route of Administration ( Oral, Injectable, Inhalation), Countries and Companies Report

Pulmonary Arterial Hypertension (PAH) Drugs Market is projected to register a 5.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022779  |   No. of Pages: 196

PTCA Balloon Catheter Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Normal balloon catheter, Drug eluting balloon catheter, Cutting balloon catheter, Scoring balloon catheter), By Delivery Platform (Rapid Exchange (RX) / Monorail balloon catheter, Over-the-wire (OTW) balloon catheter), By Compliance, Semi-Compliant, Non-Compliant), By Balloon Material (Polyolefin copolymer (POC), Polyethylene (PE), Polyethylene terephthalate (PET)), Countries and Companies Report

PTCA Balloon Catheter Market is projected to register a 6.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022778  |   No. of Pages: 199

Psoriatic Arthritis Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Antirheumatic Drugs (DMARDs), Immunosuppressants, Biologic Agents, Others), By Route of Administration (Oral, Parenteral, Others), Countries and Companies Report

Psoriatic Arthritis Therapeutics Market is projected to register a 10.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022777  |   No. of Pages: 193

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us